Table 4.
Risk Factor for Death Censored Graft Failure
| Univariate | Multivariate | |||
|---|---|---|---|---|
| Odd ratio (95% CI) | P value | Odd ratio (95% CI) | P value | |
| Donor | ||||
| Age | 1.00 (0.97-1.03) | 0.9 | ||
| Male | 1.15 (0.42-3.11) | 0.8 | ||
| BMI | 0.89 (0.75-1.06) | 0.2 | ||
| DM | 0.77 (0.09-6.06) | 0.8 | ||
| Hypertension | 2.21 (0.80-6.11) | 0.1 | ||
| Cause of death (CVA) | 1.88 (0.66-5.39) | 0.2 | ||
| AKI by KDIGO | 0.98 (0.32-3.01) | 0.9 | 1.37 (0.19-10.09) | 0.8 |
| AKI by AKIN | 0.44 (0.13-1.45) | 0.2 | 0.18 (0.02-1.40) | 0.1 |
| CVP | 1.02 (0.89-1.16) | 0.1 | ||
| MAP | 0.97 (0.94-1.01) | 0.8 | ||
| Last day urine output | 1.00 (1.00-1.00) | 0.4 | ||
| Cold ischemic time | 1.00 (0.99-1.00) | 0.4 | ||
| Recipient | ||||
| Age | 0.97 (0.92-1.02) | 0.2 | ||
| Male | 1.15 (0.45-2.94) | 0.8 | ||
| BMI | 0.83 (0.70-0.99) | 0.03 | 0.57 (0.41-0.80) | 0.002 |
| DM | 0.55 (0.12-2.45) | 0.4 | ||
| Hypertension | 1.29 (0.29-5.82) | 0.7 | ||
| GN | 1.45 (0.57-3.68) | 0.4 | ||
| Retransplantation | 1.04 (0.23-4.75) | 0.9 | ||
| PRA | 0.96 (0.91-1.02) | 0.2 | ||
| HLA MN | 1.64 (1.03-2.62) | 0.04 | ||
| ATG (Reference = Basiliximab) | 0.71 (0.16-3.18) | 0.6 | ||
| Tacrolimus (Reference = Cyclosporine) | 0.40 (0.14-1.21) | 0.1 | ||
| Delayed graft function | 1.95 (0.71-5.37) | 0.2 | 9.25 (1.93-44.33) | 0.005 |
| Acute rejection | 7.55 (2.86-19.91) | <0.001 | 6.00 (1.06-34.09) | 0.04 |
Abbreviations: CI confidence interval, BMI body mass index, DM diabetes mellitus, CVA cerebrovascular accident, KDIGO kidney disease: improving global outcome, AKIN acute kidney injury network, CVP central venous pressure, MAP mean arterial pressure, GN glomerulonephritis, PRA panel reactive antibody HLA human leukocyte antigen, MN mismatch number, ATG anti-thymocyte globulin